Dear Colleagues,
We are pleased to announce the winners of the Cancers 2022 Best Paper Award. All papers published from 1 January 2022 to 31 December 2022 in Cancers were considered for the award. After a thorough evaluation of the originality and significance of the papers, citations and downloads, four winners were selected.
Two Reviews:
Chemotherapy Side-Effects: Not All DNA Damage Is Equal
By Winnie M. C. van den Boogaard, Daphne S. J. Komninos and Wilbert P. Vermeij
Cancers. 2022, 14(3), 627; doi: 10.3390/cancers14030627
Engineering Induced Pluripotent Stem Cells for Cancer Immunotherapy
By Yang Zhou, Miao Li, Kuangyi Zhou, James Brown, Tasha Tsao, Xinjian Cen, Tiffany Husman, Aarushi Bajpai, Zachary Spencer Dunn and Lili Yang
Cancers. 2022, 14(9), 2266; doi: 10.3390/cancers14092266
Two Articles:
Accurate Screening for Early-Stage Breast Cancer by Detection and Profiling of Circulating Tumor Cells
By Timothy Crook, Robert Leonard, Kefah Mokbel, Alastair Thompson, Michael Michell, Raymond Page, Ashok Vaid, Ravi Mehrotra, Anantbhushan Ranade, Sewanti Limaye, Darshana Patil, Dadasaheb Akolkar, Vineet Datta, Pradip Fulmali, Sachin Apurwa, Stefan Schuster, Ajay Srinivasan and Rajan Datar
Cancers. 2022, 14(14), 3341; doi: 10.3390/cancers14143341
T-Cells Expressing a Highly Potent PRAME-Specific T-Cell Receptor in Combination with a Chimeric PD1-41BB Co-Stimulatory Receptor Show a Favorable Preclinical Safety Profile and Strong Anti-Tumor Reactivity
By Nadja Sailer, Ina Fetzer, Melanie Salvermoser, Monika Braun, Doris Brechtefeld, Christian Krendl, Christiane Geiger, Kathrin Mutze, Elfriede Noessner, Dolores J. Schendel, Maja Bürdek, Susanne Wilde and Daniel Sommermeyer
Cancers. 2022, 14(8), 1998; doi: 10.3390/cancers14081998
Each winner will receive CHF 500, an electronic certificate and a chance to publish a paper in Cancers in 2024 following peer review.
Please join us in congratulating the winners of the Cancers 2022 Best Paper Award. We would also like to take this opportunity to thank all of our authors for your continued support of Cancers.
Kind regards,
Cancers Editorial Office
Cancers 2022 Best Paper Award
Eligibility and Requirements
– All papers published in Cancers will be eligible (Both regular and Special Issue submissions).
Winner
Open AccessArticle
The Role of the Immune Metabolic Prognostic Index in Patients with Non-Small Cell Lung Cancer (NSCLC) in Radiological Progression during Treatment with Nivolumab
by
Matteo Bauckneht, Carlo Genova, Giovanni Rossi, Erika Rijavec, Maria Giovanna Dal Bello, Giulia Ferrarazzo, Marco Tagliamento, Maria Isabella Donegani, Federica Biello, Silvia Chiola, Lodovica Zullo, Stefano Raffa, Francesco Lanfranchi, Giuseppe Cittadini, Cecilia Marini, Egesta Lopci, Gianmario Sambuceti, Francesco Grossi and Silvia Morbelli
Winner
Open AccessEditor’s ChoiceArticle
Accurate Screening for Early-Stage Breast Cancer by Detection and Profiling of Circulating Tumor Cells
by
Timothy Crook, Robert Leonard, Kefah Mokbel, Alastair Thompson, Michael Michell, Raymond Page, Ashok Vaid, Ravi Mehrotra, Anantbhushan Ranade, Sewanti Limaye, Darshana Patil, Dadasaheb Akolkar, Vineet Datta, Pradip Fulmali, Sachin Apurwa, Stefan Schuster, Ajay Srinivasan and Rajan Datar
Open AccessEditor’s ChoiceArticle
T-Cells Expressing a Highly Potent PRAME-Specific T-Cell Receptor in Combination with a Chimeric PD1-41BB Co-Stimulatory Receptor Show a Favorable Preclinical Safety Profile and Strong Anti-Tumor Reactivity
by
Nadja Sailer, Ina Fetzer, Melanie Salvermoser, Monika Braun, Doris Brechtefeld, Christian Krendl, Christiane Geiger, Kathrin Mutze, Elfriede Noessner, Dolores J. Schendel, Maja Bürdek, Susanne Wilde and Daniel Sommermeyer
Award Committee
Dr. Samuel Mok
Chairman
UT MD Anderson Cancer Center
Prof. Donat Kögel
Klinikum der Goethe-Universität Frankfurt
Dr. Nicola Amodio
Università Magna Graecia di Catanzaro
Winner
John Maher
King’s College London, School of Cancer and Pharmaceutical Studies, Guy’s Hospital, Great Maze Pond, London SE1 9RT, UK
https://www.mdpi.com/2072-6694/11/5/674
Barbara Wegiel
Department of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA
https://www.mdpi.com/2072-6694/11/4/450
Massimo Libra
Department of Biomedical and Biotechnological Sciences, Oncologic, Clinic and General Pathology Section, University of Catania, 95123 Catania, Italy
https://www.mdpi.com/2072-6694/11/1/38
Anthony Gonçalves
Department of Medical Oncology, Aix-Marseille University, Inserm U1068, CNRS UMR7258, Institute Paoli-Calmettes, 13009 Marseille, France
https://www.mdpi.com/2072-6694/11/7/1033
Award Committee
Dr. Samuel Mok
Chairman
UT MD Anderson Cancer Center